• About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV
Friday, June 2, 2023
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
No Result
View All Result

$7m innovator support program launched to empower African health tech start-ups

June 23, 2022
Reading Time: 5 mins read
ShareShareShareShare

Healthcare consulting firm Salient Advisory has launched its latest market intelligence report highlighting promising African healthtech start-ups in supply chain.

Spurred by these findings, a consortium of global and continental organizations, with funding from Bill and Melinda Gates Foundation, has announced the launch of a pan-African initiative to support companies’ impact, access to markets and commercialization.

Salient’s report, titled ‘Innovations in Digitising Distribution of Health Products’, highlights more than 80 healthtech innovators in Kenya, Uganda, Ghana, and Nigeria. Tech-enabled approaches to digitizing medicine distribution to underserved pharmacies, drug shops, clinics and hospitals, pioneered by companies such as Lifestores, Maisha Meds and Shelf Life, recorded rapid growth in the past year, mirroring trends seen in B2B e-commerce on the African continent.

Innovators are also demonstrating an increasing interest in powering rural supply chains, improving availability of medicines, and bolstering resilience of supply chain operations.

Investor interest has also been strong; 36% of all-time funding reported by health care supply chain innovators profiled was raised in the last 12 months. However, exclusionary funding trends remain entrenched: only 2% of recent funding was raised by Black, women founders, a total of just $1.6 million in 2021.

Inspired by the progress and potential of African innovators in supply chain, the Bill & Melinda Gates Foundation, alongside Merck Sharp & Dohme (MSD), the World Health Organisation Regional Office for Africa, AUDA-NEPAD and AmerisourceBergen, are launching a $7 million pan-African initiative to provide 60 promising early and growth-stage companies with risk-tolerant grants alongside commercialization support to power their impact at scale.

The program, called Investing in Innovation (i3), is coordinated by Salient Advisory, SCIDaR, and SouthBridge A&I and is operationalized with CCHub, Startupbootcamp, IMPACT Lab, and Villgro Africa. Applications for the first cohort of 30 companies are open now, at www.innovationsinafrica.com. Applications will close in mid August.

Cheikh Oumar Seydi, Director, Africa, at the Bill and Melinda Gates Foundation, commented:

“African health innovators have shown increasing capacity to leverage technology to optimize supply chains and advance access to medicines. Such local innovations have the potential to change how supply chains and health systems function – and it is time to support them. We are pleased to be collaborating with strong global and continental partners to jointly strengthen African health systems, and accelerate progress towards universal health coverage.”

Dr Abdullahi Sheriff, AVP, Global Market Access, Sustainable Access Solutions at MSD also commented:

“There has been considerable progress in tech-driven innovation in health product distribution across Africa. Spurring and scaling disruptive innovation in health supply chain is key to expanding access to medicines for all. That’s why we, at MSD, are excited to collaborate on the i3 program.”

Dr Janet Byaruhanga, Senior Programme Officer – Health at AUDA-NEPAD also commented:

“The COVID-19 pandemic demonstrated the capacity of African innovators to leverage tech-enabled solutions to transform medicine distribution. AUDA-NEPAD will continue to leverage its mandate and comparative advantage to foster partnerships that strengthen evidence, deploy innovation, enhance policy environments and facilitate critical investments, while creating valuable and high-impact jobs across the continent.”

Speaking on the launch of the report and i3 program, Director of Salient Advisory, Remi Adeseun said:

“There has been considerable progress over the past year as supply chain innovations work to enhance access to quality medicines. Our report provides investors, donors, and governments with actionable recommendations on engagement strategies to advance companies’ growth and impact. With funding from the Bill and Melinda Gates Foundation, and along with our esteemed partners, we are excited to be launching the Investing in Innovation program to connect promising companies to customers who can power their impact and scale.”

To download the full market intelligence report, please click here.

Start-ups working in health product distribution across Africa are invited to apply for the program at http://innovationsinafrica.com/

ShareTweetSendSend
Previous Post

MTN, Bui Power Authority, others honoured at 2022 HESS Awards

Next Post

Yagaba-Kubori: Residents protest alleged police brutality after mass arrests

Related Posts

No Content Available
Next Post
Yagiba Kubori: Residents protest police brutality after mass arrests

Yagaba-Kubori: Residents protest alleged police brutality after mass arrests

TOP STORIES

Ken Ofori-Atta sues Captain Smart for defamation, demands GH¢10m

June 2, 2023

Mamprugu Overlord calls for truce between Gonjas and Mamprusis

June 2, 2023

Tamale Technical University teachers call off strike after engagement with management

June 2, 2023
Load More
ADVERTISEMENT
Citinewsroom – Comprehensive News in Ghana

CitiNewsroom.com is Ghana's leading news website that delivers high quality innovative, alternative news that challenges the status quo.

Archives

Download App

Download

Download

  • About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV

© 2023 All Rights Reserved Citi Newsroom.

No Result
View All Result
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos

© 2023 All Rights Reserved Citi Newsroom.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT